Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, Yeliz Demir, Busra Dincer, Abdulilah Ece & Şükrü Beydemir. (2023) Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now
Read now
Articles from other publishers (4)
Pinar Kul, Meral Tuncbilek, Mustafa Ergul, Ezgi Nurdan Yenilmez Tunoglu & Yusuf Tutar. (2023) A Novel 6,8,9-Trisubstituted Purine Analogue Drives Breast Cancer Luminal A Subtype
MCF-7 to Apoptosis and Senescence through Hsp70 Inhibition. Anti-Cancer Agents in Medicinal Chemistry 23:5, pages 585-598.
Crossref
Crossref
Mostafa G.M. El-Gazzar, Mostafa M. Ghorab, Mohamed A. Amin, Mohamed Korany, Mohammed A. Khedr, Marwa G. El-Gazzar & Tamer M. sakr. (2023) Computational, in vitro and radiation-based in vivo studies on acetamide quinazolinone derivatives as new proposed purine nucleoside phosphorylase inhibitors for breast cancer. European Journal of Medicinal Chemistry 248, pages 115087.
Crossref
Crossref
Yangyang Liu, Shufang Ye, Yabi Zhu, Luyi Chen & Zizhen Zhang. (2022) RIG-I Promotes Cell Viability, Colony Formation, and Glucose Metabolism and Inhibits Cell Apoptosis in Colorectal Cancer by NF-κB Signaling Pathway. Disease Markers 2022, pages 1-13.
Crossref
Crossref
Ali S. Alqahtani, Mostafa M. Ghorab, Fahd A. Nasr, Mohammad Z. Ahmed, Abdullah A. Al-Mishari & Sabry M. Attia. (2022) The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study. Molecules 27:3, pages 981.
Crossref
Crossref